JP Patent
JP2007538060A — Zd6474を含有する医薬組成物
Assigned to AstraZeneca AB · Expires 2007-12-27 · 18y expired
What this patent protects
ZD6474または薬剤的に受容できるその塩、脆性賦形剤および事実上不溶性で延性圧縮特性を有する2つめの賦形剤を含有する、医薬組成物。
USPTO Abstract
ZD6474または薬剤的に受容できるその塩、脆性賦形剤および事実上不溶性で延性圧縮特性を有する2つめの賦形剤を含有する、医薬組成物。
Drugs covered by this patent
- Caprelsa (VANDETANIB) · Sanofi
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.